# FDA Inspection 1259437 - Biomat USA, Inc. - January 16, 2025

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/89ae8d95-ffc2-4573-a769-58cad48d23e6
Source feed: FDA_Inspections

> FDA Inspection 1259437 for Biomat USA, Inc. on January 16, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1259437
- Company Name: Biomat USA, Inc.
- Inspection Date: 2025-01-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1259437 - 2025-01-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/71598f44-3fbf-4054-92dd-7a189adec9f1)
- [FDA Inspection 1096859 - 2019-06-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/acb3acea-4108-4955-9967-f4ecf8c3081e)

Company: https://www.keypedia.com/companies/biomat-usa-inc/3a302fa0-0960-4aab-a2ca-47c8e94b3fa8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d